DRONEVER
Sanofi
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85512073 |
| Registration Number | 4307596 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Susan Upton Douglass |
| Attorney Name | Susan Upton Douglass |
| Attorney Docket Number | SYN 1105236 |
| Law Office Assigned | L90 |
| Employee Name | COLLIER, DAVID E |
Timeline
| 2012-01-09 | Application Filed |
| 2013-01-08 | Published for Opposition |
| 2013-02-06 | Location: PETITIONS OFFICE |
| 2013-03-26 | Trademark Registered |
| 2019-11-01 | Cancelled |
| 2019-11-01 | Status: Dead/Cancelled |
| 2019-12-10 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Sanofi |
| Address | 54, rue de La Boétie Paris FR 75008 |
| Legal Entity Type | Corporation |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for human use for the treatment of cardiovascular diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2012-01-12 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2012-01-12 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2012-04-13 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2012-04-13 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2012-04-13 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2012-04-13 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2012-04-17 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2012-04-17 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2012-04-18 | 9 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2012-05-14 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2012-05-14 | 11 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2012-05-14 | 12 GNS3 O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2012-11-14 | 13 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2012-11-30 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2012-11-30 | 15 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2012-12-19 | 16 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2013-01-08 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2013-01-08 | 18 NPUB E:E-Mail |
| TEAS POST PUBLICATION AMENDMENT RECEIVED | 2013-01-08 | 19 EPPA I:Incoming Correspondence |
| ASSIGNED TO PETITION STAFF | 2013-01-24 | 20 APET A:Allowance for Publication |
| CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2013-02-06 | 21 CHPB I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2013-03-26 | 22 R.PR A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-01-31 | 23 CRFA I:Incoming Correspondence |
| REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | 2017-04-05 | 24 CORV 1: |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2018-03-26 | 25 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2019-11-01 | 26 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DRONEVER 85512073 4307596 Dead/Cancelled |
Sanofi 2012-01-09 |
 DRONEVER 78417931 2966955 Dead/Cancelled |
Sanofi-Synthelabo 2004-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 